Novo Nordisk A/S
Copenhagen : NOVO B

May 01, 2013 01:44 ET

Novo Nordisk A/S increased operating profit by 18% in the first quarter of 2013

BAGSVAERD, DENMARK--(Marketwired - May 1, 2013) - Financial report for the period 1 January 2013 to 31 March 2013. Sales growth of 13% driven by Victoza®, NovoRapid® and Levemir

Company announcement No 32 / 2013:

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE


Contact Information